Abnormal Expression of N6-Methyladenosine RNA Methylation Regulator IGF2BP3 in Colon Cancer Predicts a Poor Prognosis

Figure 3

Relationship between the expression of IGF2BP3 and clinicopathological features in the GSE 41258 dataset. (a) Age, (b) gender, (c) stage, (d) pathologic T-stage, (e) pathologic N-stage, (f) pathologic M-stage, (g) MSI and MSS, and (h) MSI high and MSI low.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)